These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28099845)

  • 1. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.
    Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A
    Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.
    Sciacovelli M; Guzzo G; Morello V; Frezza C; Zheng L; Nannini N; Calabrese F; Laudiero G; Esposito F; Landriscina M; Defilippi P; Bernardi P; Rasola A
    Cell Metab; 2013 Jun; 17(6):988-999. PubMed ID: 23747254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
    Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
    Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD
    Masgras I; Cannino G; Ciscato F; Sanchez-Martin C; Darvishi FB; Scantamburlo F; Pizzi M; Menga A; Fregona D; Castegna A; Rasola A
    Cell Death Differ; 2022 Oct; 29(10):1996-2008. PubMed ID: 35393510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells.
    Guzzo G; Sciacovelli M; Bernardi P; Rasola A
    Oncotarget; 2014 Dec; 5(23):11897-908. PubMed ID: 25564869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Ras-GTPase activating protein neurofibromin by C-tail phosphorylation: implications for protein kinase C/Ras/extracellular signal-regulated kinase 1/2 pathway signaling and neuronal differentiation.
    Leondaritis G; Petrikkos L; Mangoura D
    J Neurochem; 2009 Apr; 109(2):573-83. PubMed ID: 19220708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.
    Yoshida S; Tsutsumi S; Muhlebach G; Sourbier C; Lee MJ; Lee S; Vartholomaiou E; Tatokoro M; Beebe K; Miyajima N; Mohney RP; Chen Y; Hasumi H; Xu W; Fukushima H; Nakamura K; Koga F; Kihara K; Trepel J; Picard D; Neckers L
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):E1604-12. PubMed ID: 23564345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase.
    Rizza S; Montagna C; Cardaci S; Maiani E; Di Giacomo G; Sanchez-Quiles V; Blagoev B; Rasola A; De Zio D; Stamler JS; Cecconi F; Filomeni G
    Cancer Res; 2016 Jul; 76(14):4170-82. PubMed ID: 27216192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
    Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
    Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth.
    Agarwal E; Altman BJ; Seo JH; Ghosh JC; Kossenkov AV; Tang HY; Krishn SR; Languino LR; Gabrilovich DI; Speicher DW; Dang CV; Altieri DC
    J Biol Chem; 2019 Jul; 294(27):10407-10414. PubMed ID: 31097545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
    Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
    Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
    Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
    Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
    Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
    J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
    Pridgeon JW; Olzmann JA; Chin LS; Li L
    PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.
    Ono K; Karolak MR; Ndong Jde L; Wang W; Yang X; Elefteriou F
    Hum Mol Genet; 2013 Aug; 22(15):3048-62. PubMed ID: 23571107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.
    Mu X; Zhao T; Xu C; Shi W; Geng B; Shen J; Zhang C; Pan J; Yang J; Hu S; Lv Y; Wen H; You Q
    Oncotarget; 2017 Feb; 8(8):13174-13185. PubMed ID: 28061458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.